A compound having Formula I: or a pharmaceutically acceptable salt thereof, wherein X, R, R and R are as defined in the specification pharmaceutical compositions thereof and methods of use thereof. The compounds of Formula I are inhibitors of Casein kinase II (CK2) pathways.